Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05983757 · ClinicalTrials.gov registry record · NA
Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe
A NA study of Ischemic Stroke, sponsored by Raul Nogueira.
- Recruiting
- Registry status
- NA
- Development phase
- 584
- Enrollment target
- 4
- Study locations
NCT05983757: Recruiting NA study of Ischemic Stroke, sponsored by Raul Nogueira.
NCT05983757 is a NA study of Ischemic Stroke that is actively recruiting participants, run by Raul Nogueira. The registered enrollment target is 584 participants, below the 1,455-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (60% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05983757, a NA study of Ischemic Stroke, is actively recruiting participants, sponsored by Raul Nogueira.
- RECRUITING
- Registry status
- NA
- Development phase
- 584 participants
- Enrollment target
- 4
- Study locations
Study Summary
A phase III, randomized, multi-center, investigational, open label clinical trial that will examine whether treatment with endovascular thrombectomy is superior to standard medical therapy alone in patients who suffer a Distal Medium Vessel Occlusion Ischemic Stroke within 12 hours from time last seen well
Primary Outcome
Modified Rankin Scale measurement (mRS): 0=no symptoms, 1= no significant disablity despite symptoms, able to carry out all usual duties. 2= slight disability, unable to carry out all previous activities, but able to look after own affairs without assistance. 3=moderate disability, requiring some help, able to walk without assistance. 4=moderatly severe disability, unable to walk and attend to bodily needs without assistance. 5=severe disability, bedridden, incontinent and requiring total nursin
Conditions Studied
Interventions
- DEVICE Experimental: endovascular thrombectomy in patients who suffer a distal medium vessel occlusion
- OTHER Standard medical management
Study Locations (4)
Georgia
- Grady Health System - Atlanta
Iowa
- UI Health Care Medical Center - Iowa City
Ohio
- ProMedica - Toledo
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 584 participants |
| Start Date | 2024-04-02 |
| Est. Completion | 2027-11 |
| Phase | NA |
What NCT05983757 shows while recruiting
NCT05983757 is an interventional study that assigns participants to a tested intervention. The registered 584 participants enrollment target is mid-sized for trials with a published cap, below the 1,455-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (60% lower).
The record links to 1 condition, with Ischemic Stroke appearing as the primary indexed condition, and to 2 interventions - of which Experimental: endovascular thrombectomy in patients who suffer a distal medium vessel occlusion is the first listed.
NCT05983757 reports a single indexed study location in Georgia, Iowa, Ohio.
Frequently Asked Questions
What is clinical trial NCT05983757 about?
NCT05983757 is a clinical study titled "Combined Thrombectomy for Distal MediUm Vessel Occlusion StroKe". A phase III, randomized, multi-center, investigational, open label clinical trial that will examine whether treatment with endovascular thrombectomy is superior to standard medical therapy alone in patients who suffer a Distal Medium Vessel Occlusion Ischemic Stroke within 12 hours from time last se...
What is the current status of trial NCT05983757?
This trial is currently recruiting. It is a NA study. The enrollment target is 584 participants. The study started on 2024-04-02. Estimated completion is 2027-11.
What conditions does trial NCT05983757 study?
This clinical trial studies the following conditions: Ischemic Stroke.
What interventions are being tested in trial NCT05983757?
The interventions under investigation include: Experimental: endovascular thrombectomy in patients who suffer a distal medium vessel occlusion (DEVICE), Standard medical management (OTHER).
Who is sponsoring clinical trial NCT05983757?
This trial is sponsored by Raul Nogueira, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05983757 being conducted?
This trial has 4 study locations across Georgia, Iowa, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05983757's enrollment target sits among peer trials
584 14th of 66 higher than 53 of 66 other Ischemic Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ischemic Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study Of Vagus Nerve Stimulation (VNS) With Mobility Training For Gait Recovery After Chronic Ischemic Stroke
RECRUITING · NA
-
Personalized Transcranial Direct Current Stimulation in Stroke Recovery
RECRUITING · NA
-
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
RECRUITING · NA
-
StrokeNet Thrombectomy Endovascular Platform
RECRUITING · NA
-
Virtual Reality Based Rehabilitation After Ischemic Stroke
RECRUITING · NA
-
K01 Impacts of Lingual Endurance Exercise
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03840083 · 584 participants · NA
Sleep-dependent Learning in Aging
- NCT04984291 · 584 participants · NA
Zimmer Biomet Shoulder Arthroplasty PMCF
- NCT06569290 · 584 participants · NA
Refinement and Testing of Recruitment Methodology for Behavioral Medication Adherence Interventions Using Behavioral Science-based Approaches
- NCT02803957 · 585 participants · NA
Randomized Trial of the Neochord DS1000 System Versus Open Surgical Repair
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI